Nurix Therapeutics reports quarterly loss of $0.81 per share
Nurix Therapeutics, Inc. (NRIX) reported a quarterly loss of $0.81 per share, missing estimates.
The company’s loss widened from $0.52 per share a year ago.
The quarterly loss also lagged behind the consensus estimate of a loss of $0.73 per share.